| Bristol-Myers Squibb Co., Ltd. | | Press release: September 25, 2024 |
|
| On October 1st, the charity bike event “C2C4C”, where employees ride bicycles to raise money for cancer support, will finally start! |
| ~15 days, 1,800 km to deliver cheer to all those fighting cancer~ |
| | Bristol-Myers Squibb Co., Ltd. will hold a charity bike event “Continent 2 Continent 4 Cancer” (C2C4C) for 15 days starting October 1, 2024, with the aim of supporting cancer research and patients. This activity began in the United States in 2014 to raise money through running to support cancer patients and their families and to advance cancer research. This year will be the fourth time the event has been held in Japan, and approximately 60 employees from the Asia-Pacific region including Japan and the United States will participate as riders. | | Starting on October 1st and taking approximately two weeks, the riders will run in a relay style over an uneven 1,800km route from Chiba Prefecture to Tokyo via Gunma, Nagano and Gifu Prefectures. | | In order to support cancer patients through these riders, we are asking for donations from everyone who agrees with the purpose of this activity from June 3rd to October 29th. . The support funds collected through this activity, along with donations from Bristol-Myers Squibb Co., Ltd., will be delivered to Cancer Net Japan (hereinafter referred to as CNJ), a certified NPO that supports cancer patients. This information will be used to provide information and support activities to the families. | | Donation site: https://congrant.com/project/cnjdonation/11624 | | C2C4C is a Bristol-Myers Squibb (BMS) charity initiative that started in the United States and spread to Europe, Japan, and Latin America, and has raised more than $16 million to date. In Japan, 23 million yen in donations was collected through C2C4C last year, which was used to support cancer patients. Steve Sugino, President and Representative Director of Bristol-Myers Squibb Co., Ltd., said: “As “One BMS'', we will never stop as long as cancer exists. Our determination shows our strong commitment.'' | | Through these activities, Bristol-Myers Squibb Co., Ltd. aims to work closely with cancer patients and their families and build a better future together. | | About C2C4C | | “C2C4C” is a concept that is used in the United States as Coast 2 Coast 4 Cancer, in Europe as Country 2 Country 4 Cancer, and in Japan and Latin America. In America, it means Continent 2 Continent 4 Cancer (continent to continent, to overcome cancer). C2C4C began in 2014 when an American employee involved in cancer research felt strongly that he needed to do more for people facing cancer. Currently, hundreds of employees from over 30 countries are participating in C2C4C around the world. Riders engage in rigorous training and fundraising activities, and pedal while keeping cancer patients and their families in mind. | | C2C4C Japan ride route/schedule (planned) | | | About Bristol-Myers Squibb | | Bristol-Myers Squibb is a global biopharmaceutical company with a mission to develop and deliver innovative medicines to help patients with serious illnesses. For more information, please visit BMS.com , LinkedIn , Twitter , YouTube , Facebook and Instagram Please take a look. | | About certified NPO Cancer Net Japan | | It was started in 1991 when two doctors translated, published, and distributed free of charge a pamphlet for breast cancer patients in the United States. Our mission is to disseminate information based on scientific evidence so that cancer patients can receive treatment based on their own wishes. Became an NPO in 2001. We opened a dedicated secretariat in January 2007, and currently operate across the country from our bases in Tokyo and Osaka. In August 2016, we became a certified NPO corporation. The main activities are educational seminars on various types of cancer, the production of the “Know More Series'' booklets that are placed at cancer treatment partner hospitals nationwide, and the implementation of educational projects such as training courses and certification exams. In addition, the Japan Cancer Forum, which has been held annually since 2014 to disseminate the latest medical information on all cancers, including rare cancers, is one of the largest cancer awareness events targeting not only cancer patients and their families, but also the general public. It has become an event. Through these activities, we aim to create a society where cancer patients can face cancer in their own way. |
|
